The Netherlands' Radiotherapy Group is Country's First to Use Elekta's Esteya Electronic Brachytherapy to Treat Skin Cancer Patients
EDE, Netherlands, March 22, 2016 -- (Healthcare Sales & Marketing Network) -- On March 3, Radiotherapy Group clinicians at Ziekenhuis Gelderse Vallei (Ede, the Netherlands) used their Esteya® electronic brachytherapy system for the first time to treat... Devices, OncologyElekta, Esteya, brachytherapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 22, 2016 Category: Pharmaceuticals Source Type: news
Survival Benefit of SIRT in mCRC UncertainSurvival Benefit of SIRT in mCRC Uncertain
Dr David Kerr looks at a study of selective internal radiation therapy in hepatic metastatic colorectal cancer, but says the lack of survival data puts the clinical utility of SIRT in question. Medscape Oncology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 21, 2016 Category: Radiology Tags: Hematology-Oncology Commentary Source Type: news
An invitation to ESTRO 35
(European Society for Radiotherapy and Oncology (ESTRO)) The ESTRO 35 congress will feature new research results in clinical radiation oncology, radiobiology, physics, technology, patient care, radiation therapy and brachytherapy, presented by top doctors, scientists and radiation therapists from all over the world, working together for the benefit of cancer patients.The congress is expected to attract 5,000 delegates from more than 80 countries. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 26, 2016 Category: Cancer & Oncology Source Type: news
Advanced Medical Isotope hires IR firm Circadian Group
Advaned Medical Isotope Corp said Wednesday it hired medical device, pharma and biotech-focused investor relations firm Circadian Group.
Newly-retained Circadian group will focus on presenting AMIC’s past success, current corporate profile and future catalysts to potential international investors.
“Circadian Group is an excellent fit for AMIC. Circadian’s expertise in our industry at our stage of development, along with outstanding recommendations from current and past clients contributed to our decision to retain them. We believe that 2016 is going to be a pivotal year for AMIC, and we feel confident that C...
Source: Mass Device - January 22, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Oncology Radiosurgery Advanced Medical Isotope Corp. Source Type: news
IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15
RICHLAND, Wash., Jan. 14, 2016 -- (Healthcare Sales & Marketing Network) -- IsoRay Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head... Devices, Oncology, PersonnelIsoRay, brachytherapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2016 Category: Pharmaceuticals Source Type: news
Living With Cancer
Seek support in dealing with guilt about lifestyle choices Are you holding on to guilt over what might have caused your cancer? If so, focus on more positive thoughts and behaviors instead. Prostate brachytherapy This form of radiation helps treat prostate cancer. Know how you can prepare and what to expect. Take a moment to [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 18, 2015 Category: Databases & Libraries Source Type: news
AMIC reports progress on RadioGel FDA clearance
Medical isotope developer Advanced Medical Isotope (AMIC) is continuing to...Read more on AuntMinnie.comRelated Reading:
AMIC resubmits Y-90 RadioGel to FDA
AMIC nets brachytherapy-related patent
AMIC looks for European investors
AMIC and GSG form strategic alliance
AMIC submits RadioGel data to FDA (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 18, 2015 Category: Radiology Source Type: news
Study Oversells HIFU Benefits, Especially in Low-Risk PCaStudy Oversells HIFU Benefits, Especially in Low-Risk PCa
Dr Gerald Chodak disputes the conclusions of a study comparing HIFU therapy with brachytherapy for patients with low or intermediate-risk prostate cancer. Medscape Urology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 23, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Concerns Over Sudden Increase in Radiation for Skin CancerConcerns Over Sudden Increase in Radiation for Skin Cancer
The use of first-line electronic brachytherapy for nonmelanoma skin cancer has risen 20-fold, raising concerns over inappropriate use. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 21, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
My cancer and hysterectomy journey – Julie’s story
The post My cancer and hysterectomy journey – Julie’s story appeared first on Hysterectomy Association.
I’m not going to post too long a story – believe me this is just the short version (!) and I hope anyone going through a similar experience will benefit from my tale – and my positive outcome.
I was diagnosed in December 2014 with uterine cancer after suddenly starting to bleed heavily in September (hadn’t had a period for about 3 years). Initial diagnosis and MRI imaging were positive and I was led to expect a straightforward op (total abdominal hysterectomy plus ovaries), which would...
Source: The Hysterectomy Association - October 19, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories brachytherapy uterine cancer Source Type: news
My cancer and hysterectomy journey – Julie ’ s story
I’m not going to post too long a story – believe me this is just the short version (!) and I hope anyone going through a similar experience will benefit from my tale – and my positive outcome.
I was diagnosed in December 2014 with uterine cancer after suddenly starting to bleed heavily in September (hadn’t had a period for about 3 years). Initial diagnosis and MRI imaging were positive and I was led to expect a straightforward op (total abdominal hysterectomy plus ovaries), which would hopefully remove everything.
Unfortunately surgery proved to be complex; after 3 c sections my uterus wall was very...
Source: The Hysterectomy Association - October 19, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health hysterectomy stories uterine cancer Source Type: news
My cancer and hysterectomy journey – Julie ’ s story
I’m not going to post too long a story – believe me this is just the short version (!) and I hope anyone going through a similar experience will benefit from my tale – and my positive outcome.
I was diagnosed in December 2014 with uterine cancer after suddenly starting to bleed heavily in September (hadn’t had a period for about 3 years). Initial diagnosis and MRI imaging were positive and I was led to expect a straightforward op (total abdominal hysterectomy plus ovaries), which would hopefully remove everything.
Unfortunately surgery proved to be complex; after 3 c sections my uterus wall was very...
Source: The Hysterectomy Association - October 19, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health hysterectomy stories uterine cancer Source Type: news
High-Dose-Rate Brachytherapy in Prostate Cancer: What Role?High-Dose-Rate Brachytherapy in Prostate Cancer: What Role?
Dr Gerald Chodak talks about the potential role of this treatment approach, alone or in combination with intensity-modulated radiation therapy, in high-risk prostate cancer. Medscape Urology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 16, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
